Skip to main content

Table 2 PCI information of the study population

From: Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial

 

All patients (N = 2476)

Bridging therapy (n = 1242)

No bridging therapy (n = 1234)

P value

PCI target vessel

    

 Left main, n (%)

27 (1.1)

12 (0.97)

15 (1.22)

0.550

 Left anterior descending artery, n (%)

818 (33.04)

421 (33.90)

397 (32.17)

0.361

 Right coronary artery, n (%)

953 (38.49)

498 (40.10)

455 (36.87)

0.057

 Circumflex, n (%)

487 (19.67)

233 (18.76)

254 (20.58)

0.254

 Other, n (%)

512 (20.68)

259 (20.85)

253 (20.50)

0.829

Number of vessels treated per patient

    

 One vessel, n (%)

1042 (42.08)

559 (45.0)

483 (39.14)

0.003

 Two vessels, n (%)

1098 (44.35)

521 (41.94)

577 (46.76)

0.016

 Three, n (%)

196 (7.92)

95 (3.62)

91 (3.32)

0.796

 Other, n (%)

140 (5.65)

67 (5.39)

73 (5.92)

0.575

Number of stents implanted per patient, n (%)

2.20 ± 1.32

2.06 ± 1.25

2.35 ± 1.42

0.416

BMS

250 (10.10)

120 (9.66)

130 (10.53)

0.471

DES

2226 (89.90)

1122 (90.34)

1104 (89.47)

 

Mean time interval between PCI and surgery ,months

76.22 ± 29.01

80.88 ± 20.45

71.53 ± 35.80

0.348

  1. PCI percutaneous coronary intervention, DES drug-eluting stent, BMS bare metal stent